More about

Mifepristone

News
June 27, 2024
4 min read
Save

US Supreme Court dismisses appeal over Idaho’s abortion ban, allowing emergency care

US Supreme Court dismisses appeal over Idaho’s abortion ban, allowing emergency care

On Thursday, June 27, the U.S. Supreme Court formally dismissed an appeal over Idaho’s current strict abortion ban, allowing for abortions to be performed in the state in emergency situations.

News
June 24, 2024
5 min read
Save

Hypercortisolism prevalent among 24% of adults with difficult-to-control type 2 diabetes

Hypercortisolism prevalent among 24% of adults with difficult-to-control type 2 diabetes

ORLANDO — Nearly one-quarter of adults with difficult-to-control type 2 diabetes also have hypercortisolism, and treating hypercortisolism may also benefit glycemic control in those with both conditions, according to speakers.

News
June 24, 2024
2 min read
Save

Similar safety, success with mail-order telehealth, in-person abortion medication care

Similar safety, success with mail-order telehealth, in-person abortion medication care

Obtaining medication abortion after no-test telehealth screening and mail-order medication dispensing was tied to similar abortion completion rates as in-person care with ultrasonography, according to study results published in JAMA.

News
June 20, 2024
1 min read
Save

Top in women’s health: Supreme Court ruling on mifepristone; breast cancer mortality

Top in women’s health: Supreme Court ruling on mifepristone; breast cancer mortality

In Food and Drug Administration et al v. Alliance for Hippocratic Medicine et al, the Supreme Court ruled in favor of the FDA, preserving access to mifepristone for medication abortion under rules adopted in 2016.

News
June 14, 2024
2 min read
Save

US Supreme Court: Mifepristone abortion drug remains legal with no new restrictions

US Supreme Court: Mifepristone abortion drug remains legal with no new restrictions

On Thursday, the U.S. Supreme Court ruled 9-0 that access to mifepristone for medication abortion remains legal including rules adopted since 2016 loosening original dispensing requirements and gestation limits.

News
May 19, 2024
1 min read
Save

Similar success, different expulsion rates with 12-, 24-hour medication abortion regimens

Similar success, different expulsion rates with 12-, 24-hour medication abortion regimens

SAN FRANCISCO — For second-trimester medical abortion, 12- and 24-hour mifepristone-misoprostol regimens produced similar success rates, adverse effects and satisfaction but different times to mifepristone and misoprostol fetal expulsion.

News
May 13, 2024
3 min read
Save

Mail-order dispensing of mifepristone effective for medication abortion

Mail-order dispensing of mifepristone effective for medication abortion

Mail-order pharmacy dispensing of mifepristone after an in-person assessment for eligibility was effective and acceptable for people seeking medication abortion, researchers reported.

News
April 11, 2024
2 min read
Save

Survey: Many pharmacists willing to prescribe medication abortion drugs but need training

Survey: Many pharmacists willing to prescribe medication abortion drugs but need training

More than two-thirds of pharmacists in California surveyed said they would be willing to prescribe medication abortion, if legally permitted, but more than half reported lacking confidence in their knowledge of abortion drugs.

News
April 04, 2024
1 min read
Save

Top in women’s health: Future of mifepristone; Biden invests in women’s health research

Top in women’s health: Future of mifepristone; Biden invests in women’s health research

On March 26, the Supreme Court heard oral arguments regarding the accessibility, efficacy and safety of mifepristone, a drug commonly used for medication abortion.

News
April 01, 2024
2 min read
Save

Self-managed abortion medication distribution outside formal settings rose after Dobbs

Self-managed abortion medication distribution outside formal settings rose after <i>Dobbs</i>

Distribution of medication for self-managed abortion from sources outside of formal health care settings increased 6 months after the Dobbs decision, despite state-level bans and restrictions, according to findings published in JAMA.

View more